Cato BioVentures
Welcome to Cato Research
Upcoming Events & Announcements
  • October 3, 2018 -
    Cato Research Celebratory Wine Tasting in Washington, D.C. - Pioneering Drug Development Pathways for 30 Years!

  • November 5, 2018 - BIO-Europe (24th Annual International Partnering Conference)

Cato Blog
Download a Quick Overview of Our Services    Request More - Contact Our Experts
Our Services     Why Cato Research?

Cato Research (CATO) is an international regulatory and clinical contract research organization (CRO) that has been delivering successful outcomes for its clients for more than 30 years. Through highly qualified and experienced personnel located in offices across North America, Europe, Israel, and South Africa, supported by strategic alliances with selected regional CROs, CATO offers tried-and-trusted international coverage.

CATO has the advantage of integrated regulatory, clinical, and scientific expertise. Our highly talented and experienced international team offers services from preclinical through IND (or equivalent), clinical development, and marketing approval to Phase 4 postmarketing research. Our track record includes successes across many different health products, including drugs, biologics, vaccines, cell therapies (including stem cells), nutriceuticals, medical foods, devices, and diagnostics. In terms of diseases and indications, in more than 27 years of operation, CATO has been involved in a wide variety of projects with a dominant focus in oncology, neurology/CNS, and orphan drug indications. This experience includes leadership of, and involvement in some of the most challenging and innovative products.